Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Clinical trial NCT02748707 · UNKNOWN

Trial details

NCT number: NCT02748707
Sponsor: Tata Memorial Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Oral Squamous Cell Carcinoma Carcinoma of Buccal Mucosa Tongue Cancers Head and Neck Cancers

Start date: 2015-08-18
Primary completion: 2018-02-12
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.